LeMaitre Vascular, Inc. Closes Public Offering Of Common Shares

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BURLINGTON, Mass., June 4, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) (the “Company”), a provider of peripheral vascular devices and implants, today announced the closing of its previously announced underwritten public offering of 1,644,500 shares of its common stock at a price to the public of $7.00 per share. The shares include 214,500 shares of common stock sold pursuant to the over-allotment option granted by LeMaitre Vascular to the underwriters, which option was exercised in full.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC